These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
549 related items for PubMed ID: 15197743
1. Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum. Tebano MT, Pintor A, Frank C, Domenici MR, Martire A, Pepponi R, Potenza RL, Grieco R, Popoli P. J Neurosci Res; 2004 Jul 01; 77(1):100-7. PubMed ID: 15197743 [Abstract] [Full Text] [Related]
2. Adenosine A 2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors. Pintor A, Galluzzo M, Grieco R, Pèzzola A, Reggio R, Popoli P. J Neurochem; 2004 Apr 01; 89(1):152-6. PubMed ID: 15030399 [Abstract] [Full Text] [Related]
3. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation. Quarta D, Borycz J, Solinas M, Patkar K, Hockemeyer J, Ciruela F, Lluis C, Franco R, Woods AS, Goldberg SR, Ferré S. J Neurochem; 2004 Nov 01; 91(4):873-80. PubMed ID: 15525341 [Abstract] [Full Text] [Related]
4. Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington's disease versus wild-type mice. Martire A, Calamandrei G, Felici F, Scattoni ML, Lastoria G, Domenici MR, Tebano MT, Popoli P. Neurosci Lett; 2007 Apr 24; 417(1):78-83. PubMed ID: 17331645 [Abstract] [Full Text] [Related]
5. Region-specific neuroprotective effect of ZM 241385 towards glutamate uptake inhibition in cultured neurons. Pepponi R, Ferrante A, Ferretti R, Martire A, Popoli P. Eur J Pharmacol; 2009 Sep 01; 617(1-3):28-32. PubMed ID: 19619523 [Abstract] [Full Text] [Related]
6. Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum. Popoli P, Pintor A, Domenici MR, Frank C, Tebano MT, Pèzzola A, Scarchilli L, Quarta D, Reggio R, Malchiodi-Albedi F, Falchi M, Massotti M. J Neurosci; 2002 Mar 01; 22(5):1967-75. PubMed ID: 11880527 [Abstract] [Full Text] [Related]
7. Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission. Tozzi A, Tscherter A, Belcastro V, Tantucci M, Costa C, Picconi B, Centonze D, Calabresi P, Borsini F. Neuropharmacology; 2007 Nov 01; 53(6):783-9. PubMed ID: 17889039 [Abstract] [Full Text] [Related]
8. Behavioural and neurochemical characterization of the adenosine A2A receptor antagonist ST1535. Galluzzo M, Pintor A, Pèzzola A, Grieco R, Borsini F, Popoli P. Eur J Pharmacol; 2008 Jan 28; 579(1-3):149-52. PubMed ID: 18036583 [Abstract] [Full Text] [Related]
9. Modulation of glutamate release and excitotoxicity by adenosine A2A receptors. Popoli P, Frank C, Tebano MT, Potenza RL, Pintor A, Domenici MR, Nazzicone V, Pèzzola A, Reggio R. Neurology; 2003 Dec 09; 61(11 Suppl 6):S69-71. PubMed ID: 14663014 [Abstract] [Full Text] [Related]
10. Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones. Nörenberg W, Wirkner K, Illes P. Br J Pharmacol; 1997 Sep 09; 122(1):71-80. PubMed ID: 9298530 [Abstract] [Full Text] [Related]
11. Adenosine A2A receptor-induced inhibition of NMDA and GABAA receptor-mediated synaptic currents in a subpopulation of rat striatal neurons. Wirkner K, Gerevich Z, Krause T, Günther A, Köles L, Schneider D, Nörenberg W, Illes P. Neuropharmacology; 2004 Jun 09; 46(7):994-1007. PubMed ID: 15081796 [Abstract] [Full Text] [Related]
12. Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration. Minghetti L, Greco A, Potenza RL, Pezzola A, Blum D, Bantubungi K, Popoli P. J Neuropathol Exp Neurol; 2007 May 09; 66(5):363-71. PubMed ID: 17483693 [Abstract] [Full Text] [Related]
13. Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes. Brambilla R, Cottini L, Fumagalli M, Ceruti S, Abbracchio MP. Glia; 2003 Aug 09; 43(2):190-4. PubMed ID: 12838511 [Abstract] [Full Text] [Related]
14. Glial cell line-derived neurotrophic factor (GDNF) enhances dopamine release from striatal nerve endings in an adenosine A2A receptor-dependent manner. Gomes CA, Vaz SH, Ribeiro JA, Sebastião AM. Brain Res; 2006 Oct 03; 1113(1):129-36. PubMed ID: 16935271 [Abstract] [Full Text] [Related]
15. Remodeling of striatal NMDA receptors by chronic A(2A) receptor blockade in Huntington's disease mice. Martire A, Ferrante A, Potenza RL, Armida M, Ferretti R, Pézzola A, Domenici MR, Popoli P. Neurobiol Dis; 2010 Jan 03; 37(1):99-105. PubMed ID: 19804830 [Abstract] [Full Text] [Related]
16. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism. Karanian DA, Baude AS, Brown QB, Parsons CG, Bahr BA. Hippocampus; 2006 Jan 03; 16(10):834-42. PubMed ID: 16897723 [Abstract] [Full Text] [Related]
17. Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease. Tanganelli S, Sandager Nielsen K, Ferraro L, Antonelli T, Kehr J, Franco R, Ferré S, Agnati LF, Fuxe K, Scheel-Krüger J. Parkinsonism Relat Disord; 2004 Jul 03; 10(5):273-80. PubMed ID: 15196505 [Abstract] [Full Text] [Related]
18. Protection by cholesterol-extracting cyclodextrins: a role for N-methyl-D-aspartate receptor redistribution. Abulrob A, Tauskela JS, Mealing G, Brunette E, Faid K, Stanimirovic D. J Neurochem; 2005 Mar 03; 92(6):1477-86. PubMed ID: 15748165 [Abstract] [Full Text] [Related]